Works by Zhao, Lin


Results: 2716
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Molecular crosstalk in perivascular adipose tissue: mechanisms of inflammation, metabolic dysregulation, and therapeutic opportunities in cardiovascular disease.

    Published in:
    Frontiers in Cardiovascular Medicine, 2025, p. 1, doi. 10.3389/fcvm.2025.1613900
    By:
    • Zhang, Shunhong;
    • Jiang, Jun;
    • Luo, Yi;
    • Liu, Guangyue;
    • Hu, Saidi;
    • Wan, Siran;
    • Luo, Chenchen;
    • Li, Hong;
    • Li, Nian;
    • da Graça Espírito Santo Vasconcelos, Jailson;
    • Lavres Ceita de Carvalho, Leonilde;
    • Lima Bragança da Costa, Monazeri;
    • Takounjou, José Etchu;
    • Maimite Das Neves, Karem;
    • dos Ramos da Conceição, Luzimery;
    • da Costa Encarnação, Marinela;
    • Zhao, Lin-Yong
    Publication type:
    Article
    34
    35

    JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60884-1
    By:
    • Maslah, Nabih;
    • Kaci, Nina;
    • Roux, Blandine;
    • Alexe, Gabriela;
    • Marie, Raphael;
    • Pasquer, Hélène;
    • Verger, Emmanuelle;
    • De Oliveira, Rafael Daltro;
    • Culeux, Cécile;
    • Mlayah, Bochra;
    • Gauthier, Nicolas;
    • Gonzales, Fanny;
    • Zhao, Lin-Pierre;
    • Ganesan, Saravanan;
    • Gou, Panhong;
    • Ling, Frank;
    • Soret-Dulphy, Juliette;
    • Parquet, Nathalie;
    • Vainchenker, William;
    • Raffoux, Emmanuel
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42

    Realization of Kagome Kondo lattice.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60785-3
    By:
    • Song, Boqin;
    • Xie, Yuyang;
    • Li, Wei-Jian;
    • Liu, Hui;
    • Chen, Jing;
    • Tian, Shangjie;
    • Zhang, Xing;
    • Wang, Qinghong;
    • Li, Xintong;
    • Lei, Hechang;
    • Zhang, Qinghua;
    • Guo, Jian-gang;
    • Zhao, Lin;
    • Yu, Shun-Li;
    • Zhou, Xingjiang;
    • Chen, Xiaolong;
    • Ying, Tianping
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibody.

    Published in:
    Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1594213
    By:
    • Li, Jia-Xin;
    • Tan, Shi-Yu;
    • Li, Li-Qi;
    • Zheng, Yu-Hong;
    • Zhao, Lin;
    • Zhu, Hui-Rong;
    • He, Hai-Lang;
    • Zhang, Yan-Yu;
    • Li, Run-Ze;
    • Bao, Tian-Yu;
    • Zhang, Yi-Zhong;
    • Yang, Xiao-Man;
    • Zhang, Hao;
    • Chen, Hui-Hui;
    • Wu, Bo-Wen;
    • Lin, Xin;
    • Lin, Xiao-Sheng;
    • Lin, Yin Cheng;
    • Sui, Xin-Bing;
    • Xie, Ying
    Publication type:
    Article
    50